|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.592 USD | -11.01% |
|
-21.33% | -54.39% |
| 05:34pm | Biomerica Enters Distribution Deal to Provide Home Screening Tests in UAE | MT |
| Apr. 15 | Biomerica Provides Update on inFoods IBS Expansion | CI |
Biomerica, Inc. reported earnings results for the full year ended May 31, 2023. For the full year, the company reported sales was USD 5.34 million compared to USD 18.87 million a year ago. Net loss was USD 7.14 million compared to USD 4.53 million a year ago.
Basic loss per share from continuing operations was USD 0.5 compared to USD 0.36 a year ago. Diluted loss per share from continuing operations was USD 0.5 compared to USD 0.36 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -54.39% | 11.19M | |
| -2.69% | 187B | |
| -1.59% | 106B | |
| -4.33% | 66.9B | |
| +0.58% | 49.45B | |
| +16.93% | 48B | |
| +4.06% | 40.84B | |
| +3.71% | 26.48B | |
| +1.27% | 26.25B | |
| +12.96% | 24.62B |
BIOMERICA, INC. 
